Article Versions Notes

Chiappetta M, Tabacco D, Iaffaldano AG, Evangelista J, Congedo MT, Sassorossi C, Meacci E, D’Argento E, Bria E, Vita E, et al. Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics. Life. 2022; 12(11):1753. https://doi.org/10.3390/life12111753

Chiappetta, Marco, Diomira Tabacco, Amedeo Giuseppe Iaffaldano, Jessica Evangelista, Maria Teresa Congedo, Carolina Sassorossi, Elisa Meacci, Ettore D’Argento, Emilio Bria, Emanuele Vita, and et al. 2022. "Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics" Life 12, no. 11: 1753. https://doi.org/10.3390/life12111753

Chiappetta, M., Tabacco, D., Iaffaldano, A. G., Evangelista, J., Congedo, M. T., Sassorossi, C., Meacci, E., D’Argento, E., Bria, E., Vita, E., Tortora, G., Boldrini, L., Charles-Davies, D., Massaccesi, M., Martino, A., Mazzarella, C., Valentini, V., Margaritora, S., & Lococo, F. (2022). Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics. Life, 12(11), 1753. https://doi.org/10.3390/life12111753